Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000875320-25-000161
Filing Date
2025-04-03
Accepted
2025-04-03 16:04:58
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2025vertexna.htm DEFA14A 11763
2 GRAPHIC a435534-1_vertexxlogoa.jpg GRAPHIC 57262
3 GRAPHIC na1.jpg GRAPHIC 1741852
4 GRAPHIC na2.jpg GRAPHIC 1588170
  Complete submission text file 0000875320-25-000161.txt   4676413
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19319 | Film No.: 25809327
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)